Page last updated: 2024-08-24

rhodamine 123 and Abdominal Neoplasms

rhodamine 123 has been researched along with Abdominal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnett, D; Bates, SE; Caluag, Z; Chen, CC; Draper, D; Fojo, T; Frye, AR; Kelly, RJ; Luchenko, V; Oldham, RK; Robey, RW; Steinberg, SM	1

Trials

1 trial(s) available for rhodamine 123 and Abdominal Neoplasms

Article	Year
A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors. The oncologist, 2012, Volume: 17, Issue:4 Topics: Abdominal Neoplasms; Adult; Aged; Alkaloids; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Interactions; Female; Humans; Leukocytes, Mononuclear; Liver; Male; Middle Aged; Paclitaxel; Radiopharmaceuticals; Rhodamine 123; Technetium Tc 99m Sestamibi	2012

Article

Year

A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors.

The oncologist, 2012, Volume: 17, Issue:4

Topics: Abdominal Neoplasms; Adult; Aged; Alkaloids; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Interactions; Female; Humans; Leukocytes, Mononuclear; Liver; Male; Middle Aged; Paclitaxel; Radiopharmaceuticals; Rhodamine 123; Technetium Tc 99m Sestamibi

2012